These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18081623)

  • 1. Use of low-dose topiramate in substance use disorder and bodyweight control.
    Chiu YH; Lee TH; Shen WW
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):630-3. PubMed ID: 18081623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate use in alprazolam addiction.
    Michopoulos I; Douzenis A; Christodoulou C; Lykouras L
    World J Biol Psychiatry; 2006; 7(4):265-7. PubMed ID: 17071548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of add-on topiramate therapy in psychiatric patients with weight gain.
    Cates ME; Feldman JM; Boggs AA; Woolley TW; Whaley NP
    Ann Pharmacother; 2008 Apr; 42(4):505-10. PubMed ID: 18364406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate for binge eating disorder.
    De Bernardi C; Ferraris S; D'Innella P; Do F; Torre E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):339-41. PubMed ID: 15694244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.
    McElroy SL; Hudson JI; Capece JA; Beyers K; Fisher AC; Rosenthal NR;
    Biol Psychiatry; 2007 May; 61(9):1039-48. PubMed ID: 17258690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate for binge-eating disorder associated with obesity.
    Tata AL; Kockler DR
    Ann Pharmacother; 2006 Nov; 40(11):1993-7. PubMed ID: 17047134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity.
    Kotwal R; Guerdjikova A; McElroy SL; Keck PE
    Hum Psychopharmacol; 2006 Oct; 21(7):425-31. PubMed ID: 16941522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials.
    Kramer CK; Leitão CB; Pinto LC; Canani LH; Azevedo MJ; Gross JL
    Obes Rev; 2011 May; 12(5):e338-47. PubMed ID: 21438989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate: a new potential pharmacological treatment for obesity.
    Astrup A; Toubro S
    Obes Res; 2004 Dec; 12 Suppl():167S-73S. PubMed ID: 15687413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term topiramate treatment of psychotropic drug-induced weight gain: a retrospective chart review.
    Khazaal Y; Chatton A; Rusca M; Preisig M; Zullino D
    Gen Hosp Psychiatry; 2007; 29(5):446-9. PubMed ID: 17888813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension.
    Tonstad S; Tykarski A; Weissgarten J; Ivleva A; Levy B; Kumar A; Fitchet M
    Am J Cardiol; 2005 Jul; 96(2):243-51. PubMed ID: 16018851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of topiramate in adults with Prader-Willi syndrome.
    Shapira NA; Lessig MC; Lewis MH; Goodman WK; Driscoll DJ
    Am J Ment Retard; 2004 Jul; 109(4):301-9. PubMed ID: 15176917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
    Roy Chengappa K; Kupfer DJ; Parepally H; John V; Basu R; Buttenfield J; Schlicht P; Houck P; Brar JS; Gershon S
    Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity.
    Bray GA; Hollander P; Klein S; Kushner R; Levy B; Fitchet M; Perry BH
    Obes Res; 2003 Jun; 11(6):722-33. PubMed ID: 12805393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate in the treatment of severe bulimia nervosa with comorbid mood disorders: a case series.
    Barbee JG
    Int J Eat Disord; 2003 May; 33(4):468-72. PubMed ID: 12658677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topiramate in substance-related and addictive disorders].
    Cohen J; Dervaux A; Laqueille X
    Presse Med; 2014 Sep; 43(9):892-901. PubMed ID: 25027463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebound of weight gain following topiramate cessation.
    Khazaal Y; Zullino DF
    Pharmacopsychiatry; 2007 Mar; 40(2):85-6. PubMed ID: 17447182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.